documents: FDA-2017-D-6784-0002
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2017-D-6784-0002 | FDA | FDA-2017-D-6784 | Implementation of Pathogen Reduction Technology in the Manufacture of Blood Components in Blood Establishments: Questions and Answers Draft Guidance for Industry | Other | Guidance | 2017-12-27T05:00:00Z | 2017 | 12 | 2017-12-27T05:00:00Z | 2018-03-28T03:59:59Z | 2024-11-07T01:15:33Z | 1 | 0 | 0900006482d77d2d |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref